Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-01-07
1994-11-15
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514256, 514337, 544326, 544328, 544329, 546271, 546274, 546275, 546276, 546304, 548254, 549 61, 549474, C07D40112, C07D21542, A61K 31435
Patent
active
053648692
ABSTRACT:
Compounds are disclosed having the formula: ##STR1## wherein D is a substituted heterocycle, especially substituted pyridyl, E-G is a linking group, especially --N(R.sub.5)--CH.sub.2 --, and Q is a substituted phenyl or substituted heterocyclic group, especially substituted benzothiopene. The compounds of the invention are angiotensin II receptor antagonists.
REFERENCES:
patent: 4551468 (1985-11-01), Cross et al.
patent: 4611059 (1986-09-01), Sih
patent: 4698352 (1987-10-01), Narith et al.
patent: 5021444 (1991-06-01), Trada et al.
Abbott Laboratories
Crowley Steven R.
Higel Floyd D.
LandOfFree
Heterocycle-substituted benzyaminopyridine angiotensin II recept does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocycle-substituted benzyaminopyridine angiotensin II recept, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycle-substituted benzyaminopyridine angiotensin II recept will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1098004